| NCT00812058 | A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression | COMPLETED | PHASE2 | 2008-11 | 2010-12 | 2010-12 |
| NCT00660335 | Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas | COMPLETED | PHASE3 | 2008-03 | 2009-10 | 2009-10 |
| NCT00322764 | Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression | COMPLETED | PHASE2 | 2006-03 | | |
| NCT00036231 | Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction | TERMINATED | PHASE3 | 2002-04 | | |
| NCT00036244 | Synthetic Human Secretin in Children With Autism | COMPLETED | PHASE3 | 2002-04 | 2004-01 | |
| NCT00060515 | RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease | TERMINATED | PHASE1 | | | |